Twist Bioscience Corp’s recent filing unveils that its Chief Financial Officer Laponis Adam unloaded Company’s shares for reported $0.25 million on Jan 10 ’25. In the deal valued at $43.26 per share,5,886 shares were sold. As a result of this transaction, Laponis Adam now holds 110,096 shares worth roughly $5.55 million.
Then, CHESS ROBERT sold 5,000 shares, generating $250,000 in total proceeds. Upon selling the shares at $50.00, the Director now owns 16,641 shares.
Before that, Laponis Adam bought 5,886 shares. Twist Bioscience Corp shares valued at $254,645 were divested by the Officer at a price of $43.26 per share.
Wolfe Research initiated its Twist Bioscience Corp [TWST] rating to an Outperform in a research note published on December 13, 2024; the price target was $60. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early June with a ‘”a Buy”‘ rating. Goldman also remained covering TWST and has increased its forecast on January 17, 2024 with a “Buy” recommendation from previously “Neutral” rating. Berenberg started covering the stock on September 27, 2023. It rated TWST as “a Buy”.
Price Performance Review of TWST
On Tuesday, Twist Bioscience Corp [NASDAQ:TWST] saw its stock jump 6.08% to $50.45. Over the last five days, the stock has gained 15.76%. Twist Bioscience Corp shares have risen nearly 8.56% since the year began. Nevertheless, the stocks have risen 49.04% over the past one year. While a 52-week high of $60.90 was reached on 01/21/25, a 52-week low of $27.41 was recorded on 01/13/25. SMA at 50 days reached $46.42, while 200 days put it at $44.78.
Levels Of Support And Resistance For TWST Stock
The 24-hour chart illustrates a support level at 48.67, which if violated will result in even more drops to 46.90. On the upside, there is a resistance level at 51.79. A further resistance level may holdings at 53.14. The Relative Strength Index (RSI) on the 14-day chart is 60.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.90, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 8.83%. Stochastics %K at 72.66% indicates the stock is a holding.
How much short interest is there in Twist Bioscience Corp?
A steep rise in short interest was recorded in Twist Bioscience Corp stocks on 2024-10-31, growing by 0.32 million shares to a total of 9.02 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 8.7 million shares. There was a rise of 3.53%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
